Expert Opinion on Drug Discovery, Volume 16, Issue 12 (2021)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Drug Discovery, Volume 16, Issue 12 (2021)

See all volumes and issues
Vol 19, 2024 Vol 18, 2023 Vol 17, 2022 Volume 16, 2021 Vol 15, 2020 Vol 14, 2019 Vol 13, 2018 Vol 12, 2017 Vol 11, 2016 Vol 10, 2015 Vol 9, 2014 Vol 8, 2013 Vol 7, 2012 Vol 6, 2011 Vol 5, 2010 Vol 4, 2009 Vol 3, 2008 Vol 2, 2007 Vol 1, 2006
Download citations Download PDFs Download issue

Editorial

Editorial
How necessary are animal models for modern drug discovery?
Vijay K Singh & Thomas M Seed
Pages: 1391-1397
Published online: 03 Sep 2021
First Page PreviewforHow necessary are animal models for modern drug discovery? | Full Text | References | PDF (812.1 KB) | EPUB
  • 16287 Views
  • 19 CrossRef citations
  • 0Altmetric
Free Access
Editorial
How can we improve peptide drug discovery? Learning from the past
David J. Craik & Meng-Wei Kan
Pages: 1399-1402
Published online: 04 Aug 2021
First Page PreviewforHow can we improve peptide drug discovery? Learning from the past | Full Text | References | PDF (171.1 KB) | EPUB
  • 6554 Views
  • 11 CrossRef citations
  • 0Altmetric
Free Access

Drug Discovery Case History

Article
An overview of the preclinical discovery and development of bamlanivimab for the treatment of novel coronavirus infection (COVID-19): reasons for limited clinical use and lessons for the future
Marco Tuccori, Irma Convertino, Sara Ferraro, Giulia Valdiserra, Emiliano Cappello, Elisabetta Fini & Daniele Focosi
Pages: 1403-1414
Published online: 30 Jul 2021
AbstractforAn overview of the preclinical discovery and development of bamlanivimab for the treatment of novel coronavirus infection (COVID-19): reasons for limited clinical use and lessons for the future | Full Text | References | PDF (354 KB) | EPUB
  • 2214 Views
  • 11 CrossRef citations
  • 0Altmetric

Perspective

Article
What is the gold standard model for Alzheimer’s disease drug discovery and development?
Ramón Cacabelos, Iván Carrera, Olaia Martínez-Iglesias, Natalia Cacabelos & Vinogran Naidoo
Pages: 1415-1440
Published online: 25 Aug 2021
AbstractforWhat is the gold standard model for Alzheimer’s disease drug discovery and development? | Full Text | References | PDF (2 MB) | EPUB
  • 691 Views
  • 6 CrossRef citations
  • 0Altmetric

Review

Article
Evolution of the drug-target residence time model
Robert A. Copeland
Pages: 1441-1451
Published online: 01 Jul 2021
AbstractforEvolution of the drug-target residence time model | Full Text | References | PDF (737.3 KB) | EPUB
  • 717 Views
  • 13 CrossRef citations
  • 0Altmetric
An update on the importance of plasma protein binding in drug discovery and development
Li Di
Pages: 1453-1465
Published online: 17 Aug 2021
AbstractforAn update on the importance of plasma protein binding in drug discovery and development | Full Text | References | PDF (1 MB) | EPUB
  • 2194 Views
  • 13 CrossRef citations
  • 0Altmetric
Recent advances in proteolytic stability for peptide, protein, and antibody drug discovery
Xianyin Lai, Jason Tang & Mohamed E.H. ElSayed
Pages: 1467-1482
Published online: 30 Jun 2021
AbstractforRecent advances in proteolytic stability for peptide, protein, and antibody drug discovery | Full Text | References | PDF (2 MB) | EPUB
  • 603 Views
  • 12 CrossRef citations
  • 0Altmetric
Article
Drug discovery strategies for novel leukotriene A4 hydrolase inhibitors
Till A Röhn, Shin Numao, Heike Otto, Christian Loesche & Gebhard Thoma
Pages: 1483-1495
Published online: 16 Jul 2021
AbstractforDrug discovery strategies for novel leukotriene A4 hydrolase inhibitors | Full Text | References | PDF (2 MB) | EPUB
  • 405 Views
  • 5 CrossRef citations
  • 0Altmetric
Glycyrrhetinic acid: a promising scaffold for the discovery of anticancer agents
Hidayat Hussain, Iftikhar Ali, Daijie Wang, Faruck L. Hakkim, Bernhard Westermann, Ishtiaq Ahmed, Ahmed M. Ashour, Amjad Khan, Amjad Hussain, Ivan R. Green & Syed Tasadaque Ali Shah
Pages: 1497-1516
Published online: 30 Jul 2021
AbstractforGlycyrrhetinic acid: a promising scaffold for the discovery of anticancer agents | Full Text | References | PDF (3.2 MB) | EPUB
  • 4425 Views
  • 15 CrossRef citations
  • 0Altmetric
Open Access
Retinoic acid-related orphan receptor gamma t (RORγt) inverse agonists/antagonists for the treatment of inflammatory diseases – where are we presently?
Christian Gege
Pages: 1517-1535
Published online: 07 Jul 2021
AbstractforRetinoic acid-related orphan receptor gamma t (RORγt) inverse agonists/antagonists for the treatment of inflammatory diseases – where are we presently? | Full Text | References | PDF (2 MB) | EPUB
  • 940 Views
  • 10 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

The value of protein allostery in rational anticancer drug design: an update
Ruth Nussinov et al.
Review Article | Published online: 28 Jul 2024
Open Access
Complementary strategies to be used in conjunction with animal models for multiple sclerosis drug discovery: adapting preclinical validation of drug candidates to the need of remyelinating strategies
Imane Charmarke-Askar et al.
Review Article | Published online: 22 Jul 2024
What impact does tautomerism have on drug discovery and development?
Devendra K. Dhaked et al.
Editorial | Published online: 16 Jul 2024
Free Access
Polypharmacology prediction: the long road toward comprehensively anticipating small-molecule selectivity to de-risk drug discovery
Leticia Manen-Freixa et al.
Review Article | Published online: 14 Jul 2024
View all latest articles